TECHWIRE 30
(CIX: WRAL30)  1,123.00    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: Apple)  100.96    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NY: QUINTILES)  57.32    (0 %)  Updated: 06:40 PM EDT, Sep 19 2014
(OP: BASF SE)  99.23    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: BioCryst)  10.93    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: BioDelivery)  17.02    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: CEMP)  9.92    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: Cisco Systems)  25.20    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: Cree)  42.16    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: DARA)  1.18    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NY: EMC CORPORATION)  29.53    (0 %)  Updated: 06:40 PM EDT, Sep 19 2014
(NQ: Extreme Networks)  4.80    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: FB)  77.91    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NY: GLAXOSMITHKLINE)  47.38    (0 %)  Updated: 06:40 PM EDT, Sep 19 2014
(NQ: GOOG)  596.08    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NY: IBM)  194.00    (0 %)  Updated: 06:40 PM EDT, Sep 19 2014
(NY: LH)  106.12    (0 %)  Updated: 06:40 PM EDT, Sep 19 2014
(OP: Lenovo Group)  31.10    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NY: MRK)  60.49    (0 %)  Updated: 06:40 PM EDT, Sep 19 2014
(NQ: Microsoft Corp)  47.52    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: NTAP)  43.00    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NY: NOVARTIS AG)  93.90    (0 %)  Updated: 06:40 PM EDT, Sep 19 2014
(OP: Novozymes A/S)  44.80    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NY: PFIZER)  30.40    (0 %)  Updated: 06:40 PM EDT, Sep 19 2014
(NQ: Pozen)  7.89    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NY: RED HAT)  57.93    (0 %)  Updated: 06:40 PM EDT, Sep 19 2014
(NQ: BBRY)  10.89    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: Salix)  164.23    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: SQI)  15.96    (0 %)  Updated: 08:10 PM EDT, Sep 19 2014

Posts tagged “BDSI”

September 7, 2010

Premium Lock Former exec at Closure Medical joins BioDelivery Sciences

BDSI Benny Ward takes over as business and strategic development director at the drug delivery technology development firm.

May 10, 2010

Premium Lock BioDelivery Sciences wins Canadian approval for painkiller

BDSI The Raleigh-based firm can now sell its “breakthrough” pain killer drug outside of the U.S. It is seeking approval to sell Onsolis in Europe.

Updated April 20, 2010

Premium Lock BioDelivery Sciences stock plunges after $10M deal disclosed

BDSI The announced sale sends BDSI shares down 14 percent from Monday’s closing price of $4.21 per share.

September 2, 2009

Premium Lock BioDelivery Sciences closing lab in New Jersey, cutting five jobs

BDSI Chief science officer is also leaving drug development firm, which recently won FDA approval for its first product.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll